Lecture image placeholder

Premium content

Access to this content requires a subscription. You must be a premium user to view this content.

Monthly subscription - $9.99Pay per view - $4.99Access through your institutionLogin with Underline account
Need help?
Contact us
Lecture placeholder background
VIDEO DOI: https://doi.org/10.48448/tzp7-jm96

technical paper

ENDO 2021

March 21, 2021

Live on Underline

Estimabl2: Is There a Need for Radioiodine Ablation in Low Risk Differentiated Thyroid Cancer (DTC) Patients ? : Results From the French Randomized Phase III Prospective Trial on 776 Patients (NCT 01837745)

Please log in to leave a comment

Downloads

Transcript English (automatic)

Next from ENDO 2021

Thyroid Immune-Related Adverse Events Following Checkpoint Inhibitor Treatment
technical paper

Thyroid Immune-Related Adverse Events Following Checkpoint Inhibitor Treatment

ENDO 2021

21 March 2021

Similar lecture

Surveillance of the Patient Who Has Had Therapeutic Hemithyroidectomy for Thyroid Cancer
technical paper

Surveillance of the Patient Who Has Had Therapeutic Hemithyroidectomy for Thyroid Cancer

ENDO 2021

21 March 2021

Stay up to date with the latest Underline news!

PRESENTATIONS

  • All Lectures
  • For Librarians
  • Resource Center
  • Free Trial
Underline Science, Inc.
1216 Broadway, 2nd Floor, New York, NY 10001, USA

© 2023 Underline - All rights reserved